Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression profiling in acute myeloid leukemia.

Peter J M Valk1, Ruud Delwel, Bob Löwenberg

  • 1Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Current Opinion in Hematology
|December 18, 2004
PubMed
Summary

Gene expression profiling (GEP) offers promising insights into classifying acute myeloid leukemia (AML). This technology identifies disease subtypes and can predict clinical outcomes, paving the way for improved diagnostics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

HemaSphere·2026
Same author

SOHO State of the Art Updates and Next Questions | Implementing Next-Generation Sequencing (NGS) in Resource-Constrained Settings: The Experience of the International Consortium on Acute Leukemias (ICAL).

Clinical lymphoma, myeloma & leukemia·2026
Same author

Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy <i>versus</i> liposomal cytarabine and daunorubicin.

Haematologica·2026
Same author

Bone phenotype of patients with telomere biology disorders.

Bone·2026
Same author

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Blood advances·2026
Same author

The impact of scaRNA12 deregulation on p53-mediated cellular stress response in B-cell precursor acute lymphoblastic leukaemia.

British journal of haematology·2026

Area of Science:

  • Molecular Biology
  • Oncology
  • Genomics

Background:

  • Acute myeloid leukemia (AML) classification relies on various factors.
  • Gene expression profiling (GEP) is an emerging technology with potential in AML research.

Purpose of the Study:

  • To review the promises of GEP in AML.
  • To summarize current knowledge on GEP for AML classification and discovery of novel disease entities.

Main Methods:

  • Review of existing gene expression profiling studies in AML.
  • Analysis of unsupervised and supervised learning approaches in GEP data.
  • Evaluation of concordance and technical challenges in GEP platforms.

Main Results:

  • Unsupervised GEP analyses identify known and novel AML classes.

Related Experiment Videos

  • Prognostic molecular signatures can be derived from GEP data.
  • Supervised analyses accurately predict AML subsets using minimal gene sets.

    • Conclusions:

    • GEP studies show high concordance, confirming methodological robustness for clinical diagnostics.
    • Technical challenges include data conversion between platforms and understanding biologic factor effects.
    • GEP, combined with other high-throughput approaches, may lead to comprehensive AML diagnostics.